Serum Concentrations of TIM-3, LAG-3, and PD-1 in Patients with Hemorrhagic Fever with Renal Syndrome

被引:0
|
作者
Safranko, Zeljka Macak [1 ]
Jakopec, Lana [1 ]
Svagusa, Karla [1 ]
Krajinovic, Lidija Cvetko [1 ]
Tomasovic, Domagoj [1 ]
Lukic, Ljiljana [1 ]
Markotic, Alemka [1 ,2 ,3 ]
机构
[1] Univ Hosp Infect Dis Dr Fran Mihaljev, Res Unit, Zagreb 10000, Croatia
[2] Univ Rijeka, Fac Med, Rijeka 51000, Croatia
[3] Catholic Univ Croatia, Fac Med, Zagreb 10000, Croatia
来源
LIFE-BASEL | 2024年 / 14卷 / 05期
关键词
orthohantavirus; HFRS; PUUV; inhibitory receptors; immune regulations; TIM-3; LAG-3; PD-1; T-CELL EXHAUSTION; INHIBITORY RECEPTORS; EXPRESSION; VIRUS; PROTEIN; HANTAVIRUSES; ACTIVATION; MACROPHAGE; AUTOIMMUNE; RESPONSES;
D O I
10.3390/life14050551
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Hemorrhagic fever with renal syndrome (HFRS) is a rodent-borne disease widespread in Europe and Asia. HFRS is caused by negative-sensed single-stranded RNA orthohantaviruses transmitted to humans through inhaling aerosolized excreta of infected rodents. Symptoms of HFRS include acute kidney injury, thrombocytopenia, hemorrhages, and hypotension. The immune response raised against viral antigens plays an important role in the pathogenesis of HFRS. Inhibitory co-receptors are essential in regulating immune responses, mitigating immunopathogenesis, and reducing tissue damage. Our research showed an increased soluble form of inhibitory co-receptors TIM-3, LAG-3, and PD-1 in HFRS patients associated with disease severity. Our study aimed to investigate the impact of HFRS on the concentrations of soluble forms of inhibitory receptors TIM-3, LAG-3, and PD-1 in the patient's serum and the potential correlation with key clinical parameters. Our study aimed to investigate the impact of HFRS on the concentrations of soluble forms of inhibitory receptors TIM-3, LAG-3, and PD-1 in the patient's serum and their possible association with relevant clinical parameters. Using multiplex immunoassay, we found elevated levels of TIM-3, LAG-3, and PD-1 proteins in the serum of HFRS patients. Furthermore, increased levels were associated with creatinine, urea, lactate dehydrogenase concentrations, and platelet count. These findings suggest that these proteins play a role in regulating the immune response and disease progression.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Targeting PD-1, TIM-3 and LAG-3 in combination for improved immunotherapy combinations
    Kehry, Marilyn
    Horlick, Robert
    Bowers, Peter
    Jun, Toni
    Correia, Jean da Silva
    Graves, Jonathan
    Wang, Yan
    Laken, Haley
    King, David J.
    CANCER RESEARCH, 2015, 75
  • [2] Simultaneous measurement and significance of PD-1, LAG-3 and TIM-3 expression in human solid tumors
    Morgado, Micaela
    Datar, Ila
    Wang, Jun
    Sanmamed, Miguel F.
    McEachern, Kristen
    Jenkins, David
    Chen, Lieping
    Carvajal-Hausdorf, Daniel
    Rimm, David L.
    Herbst, Roy S.
    Schalper, Kurt A.
    CANCER RESEARCH, 2018, 78 (13)
  • [3] Tim-3, Lag-3, and TIGIT
    Joller, Nicole
    Kuchroo, Vijay K.
    EMERGING CONCEPTS TARGETING IMMUNE CHECKPOINTS IN CANCER AND AUTOIMMUNITY, 2017, 410 : 127 - 156
  • [4] Abundant expression of TIM-3, LAG-3, PD-1 and PD-L1 as immunotherapy checkpoint targets in effusions of mesothelioma patients
    Marcq, Elly
    De Waele, Jorrit
    Van Audenaerde, Jonas
    Lion, Eva
    Santermans, Eva
    Hens, Niel
    Pauwels, Patrick
    van Meerbeeck, Jan P.
    Smits, Evelien L. J.
    ONCOTARGET, 2017, 8 (52) : 89722 - 89735
  • [5] Assessment of the expression and response of PD-1, LAG-3, and TIM-3 after neoadjuvant radiotherapy in rectal cancer
    Peng, Qing-Qin
    Li, Jin-Luan
    Xin, Pei-Ling
    Du, Kai-Xin
    Lin, Xiao-Yi
    Wu, Jun-Xin
    Zhang, Mu-Tian
    Kong, Xiang-Quan
    NEOPLASMA, 2021, 68 (04) : 742 - +
  • [6] PD-1, TIM-3, and LAG-3 Expression in T Cells in a Patient with Recurrent Ossifying Fibroma: A Case Report
    Garcia-Munoz, Alejandro
    Goreti Nieto-Velazquez, Nayeli
    Damian-Morales, Gabriela
    Liceaga-Escalera, Carlos
    Alberto Montoya-Perez, Luis
    Cruz-Velez, Madeleine
    Antonio Gomez-Hernandez, Pabel
    Trejo-Iriarte, Cynthia
    Pastelin-Palacios, Rodolfo
    Adan Moreno-Eutimio, Mario
    INTERNATIONAL JOURNAL OF MOLECULAR AND CELLULAR MEDICINE, 2020, 9 (04) : 307 - 311
  • [7] Immune Checkpoint Profiling in Humanized Breast Cancer Mice Revealed Cell-Specific LAG-3/PD-1/TIM-3 Co-Expression and Elevated PD-1/TIM-3 Secretion
    Bruss, Christina
    Kellner, Kerstin
    Albert, Veruschka
    Hutchinson, James A.
    Seitz, Stephan
    Ortmann, Olaf
    Brockhoff, Gero
    Wege, Anja K.
    CANCERS, 2023, 15 (09)
  • [8] PD-L1, PD-1, LAG-3, and TIM-3 in Melanoma: Expression in Brain Metastases Compared to Corresponding Extracranial Tumors
    Wang, Jaeyun Jane
    Burger, Peter
    Taube, Janis
    Soni, Abha
    Chaichana, Kaisorn
    Sheu, Mary
    Belcaid, Zineb
    Jackson, Christopher
    Lim, Michael
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (12)
  • [9] Simultaneous measurement and clinical significance of PD-1, LAG-3 and TIM-3 in non-small cell lung cancer (NSCLC)
    Datar, Ila J.
    Wang, Jun
    Mani, Nikita
    Villarroel-Espindola, Franz
    Ryan, Patrick
    Sanmamed, Miguel F.
    McEachern, Kristen
    Jenkins, David
    Rimm, David L.
    Chen, Leiping
    Herbst, Roy
    Schalper, Kurt
    CANCER RESEARCH, 2017, 77
  • [10] Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy
    Letong Cai
    Yuchen Li
    Jiaxiong Tan
    Ling Xu
    Yangqiu Li
    Journal of Hematology & Oncology, 16